Search
Endocrine System Diseases
go.drugbank.com/conditions/DBCOND0031899Synonyms: Endocrine, nutritional, metabolic and immunity disorders, Endocrine &/or [nutritional], [metabolic] and [immunity] disordersAlbiglutide
go.drugbank.com/drugs/DB09043ApprovedInvestigationalWithdrawnAlbiglutide is a glucagon-like peptide-1 agonist (GLP-1) biologic drug indicated in the treatment of type 2 diabetes. It is marketed under the brands Eperzan and Tanzeum by GSK (GlaxoSmithKline). … It is a dipeptidyl peptidase-4-resistant glucagon-like peptide-1 dimer fused to human albumin. Albiglutide was approved on April 15, 2014 by the FDA.
Categories: Drugs Used in Diabetes, Alimentary Tract and MetabolismPsychiatric anxiety
go.drugbank.com/conditions/DBCOND0099705Drugs: Acetylsalicylic acid · Amoxapine · Buspirone · Chlordiazepoxide · Clobazam · Clotiazepam +27 moreSynonyms: Mixed anxiety and depressive disorder, [X]Mixed anxiety and depressive disorderNiraparib
go.drugbank.com/drugs/DB11793ApprovedInvestigationalNiraparib is an orally active poly (ADP-ribose) polymerase (PARP) inhibitor. By blocking the enzymes responsible for DNA repair, niraparib induces cytotoxicity in cancer cells. … [L43277] Niraparib was approved by the European Commission on November 16, 2017 [L43742] and by Health Canada on June 27, 2019.
Categories: niraparib and abiraterone, Antineoplastic and Immunomodulating AgentsType III hyperlipidaemia
go.drugbank.com/conditions/DBCOND0008344Drugs: DoconexentSynonyms: Familial hyperbetalipoproteinemia and hyperprebetalipoproteinemia, Familial hyperbetalipoproteinaemia and hyperprebetalipoproteinaemiaAttapulgite
go.drugbank.com/drugs/DB01574ApprovedVet approvedWithdrawnWhen used in medicine, it physically binds to acids and toxic substances in the stomach and digestive tract. For that reason, it has often been used in antidiarrheal medications. … Attapulgite is a magnesium aluminium phyllosilicate which occurs in a type of clay soil common to the Southeastern United States.
Mixtures: Diban Cap, Diban CapCategories: Alimentary Tract and Metabolism, Compounds used in a research, industrial, or household settingDiabetic Ketoacidosis
go.drugbank.com/conditions/DBCOND0000979Synonyms: Ketoacidosis in diabetes mellitusMoxetumomab pasudotox
go.drugbank.com/drugs/DB12688ApprovedInvestigational[A38864] MxP appears as an improved form of BL22 by the mutation of the Fv region and the antibody phage-displayed. As well the residues SSY in the heavy chain are mutated to THW. … [A38864] It was developed by Astra Zeneca and FDA approved on September 13, 2018, after being granted the status of Fast Track, Priority Review and Orphan Drug designations.[L4568]
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsSodium tartrate
go.drugbank.com/drugs/DB13707ApprovedWithdrawnSodium tartrate is generally recognized as safe (GRAS) as a direct human food ingredient. It acts as an emulsifier and pH control agent in food products [L2590]. … Sodium tartrate is a disodium salt of l-( + )-tartaric acid that is identified by transparent, colorless, and odorless crystals. It is obtained as a byproduct of wine manufacturing.
Categories: Alimentary Tract and MetabolismRibociclib
go.drugbank.com/drugs/DB11730ApprovedInvestigationalThese proteins, when over-activated, can enable cancer cells to grow and divide too quickly. Ribociclib was approved by the FDA in March 2017 under the brand name Kisqali. … Ribociclib is a selective cyclin-dependent kinase inhibitor, a class of drugs that help slow the progression of cancer by inhibiting two proteins called cyclin-dependent kinase 4 and 6 (CDK4/6).
Categories: Antineoplastic and Immunomodulating AgentsProducts: KRYXANA (200MG), KISQALI FILM-COATED TABLET 200MG